Biotech entity
All 1 tracked stories fall under one category: fda-approval. Towards Buddha Co., Ltd. is most often covered alongside ARP-W/WG Series, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Towards Buddha Co., Ltd. appears in 1 tracked Biotech story from August 26, 2026.
Last mentioned: 20h ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: fda-approval. Towards Buddha Co., Ltd. is most often covered alongside ARP-W/WG Series, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Towards Buddha Co., Ltd. appears in 1 tracked Biotech story from August 26, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Towards Buddha Co., Ltd.. Shared-story counts are live from our verified record — not editorial picks.
Biomaterials and medtech R&D teams get a technical look at ICP DAS-BMP's TPU formulations: low-migration ARP-B20 for 90-day implants, radiopaque B20/B40 and W/WG lines for visibility, and EARP for precision components. The showcase occurs at Medical Manufacturing Asia 2026.
Source: malaysiasun.com · philippinetimes.com
Towards Buddha Co., Ltd. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
